Langley PC. Rush to Judgement: Imaginary Worlds and Cost-Outcomes Claims for PCSK9 Inhibitors. Innov Pharm [Internet]. 2017 May 16 [cited 2024 Apr. 26];8(2). Available from: https://pubs.lib.umn.edu/index.php/innovations/article/view/516